These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on the optical enantiomorphs of warfarin in man. O'Reilly RA Clin Pharmacol Ther; 1974 Aug; 16(2):348-54. PubMed ID: 4605176 [No Abstract] [Full Text] [Related]
4. The assay of warfarin in plasma or stool. Lewis RJ; Ilnicki LP; Carlstrom M Biochem Med; 1970 Dec; 4(5):376-82. PubMed ID: 5524077 [No Abstract] [Full Text] [Related]
5. Assay of warfarin. Lewis RJ J Pharm Sci; 1971 Aug; 60(8):1271-2. PubMed ID: 5127112 [No Abstract] [Full Text] [Related]
6. Determination of warfarin in human plasma by high performance liquid chromatography. Chan K; Woo KS Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):699-703. PubMed ID: 3221742 [TBL] [Abstract][Full Text] [Related]
7. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. Hewick DS; McEwen J J Pharm Pharmacol; 1973 Jun; 25(6):458-65. PubMed ID: 4146584 [No Abstract] [Full Text] [Related]
8. Metabolism and excretion of 14 C-labeled warfarin and 14 C-labeled vitamin K 1 by isolated rat liver. Losito RJ; Owen CA Mayo Clin Proc; 1972 Oct; 47(10):731-8. PubMed ID: 4635564 [No Abstract] [Full Text] [Related]
9. Comparative pharmacokinetics of coumarin anticoagulants. V. Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man. Nagashima R; Levy G J Pharm Sci; 1969 Jul; 58(7):845-9. PubMed ID: 4185728 [No Abstract] [Full Text] [Related]
10. Quantitative determination of butaperazine by TLC. Kapadia AJ; Barber MA; Martin AE J Pharm Sci; 1970 Oct; 59(10):1476-9. PubMed ID: 4394317 [No Abstract] [Full Text] [Related]
11. GLC determination of warfarin in human plasma. Kaiser DG; Martin RS J Pharm Sci; 1974 Oct; 63(10):1579-81. PubMed ID: 4436791 [No Abstract] [Full Text] [Related]
13. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. Andreasen PB; Vesell ES Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464 [No Abstract] [Full Text] [Related]
14. [Identification of agents in toxicologic analysis using 1.2-dichlorethane extraction, thin-layer chromatography and U.V.-spectrophotometry]. Drost RH; Reith JF Pharm Weekbl; 1970 Oct; 105(40):1129-38. PubMed ID: 5506769 [No Abstract] [Full Text] [Related]
15. Comparison of high-performance liquid chromatography and a spectrophotometric technique for determining plasma warfarin. Forman WB; Shlaes J J Chromatogr; 1978 Nov; 146(3):522-6. PubMed ID: 721931 [No Abstract] [Full Text] [Related]
16. Three-phase hollow fiber liquid phase microextraction of warfarin from human plasma and its determination by high-performance liquid chromatography. Hadjmohammadi M; Ghambari H J Pharm Biomed Anal; 2012 Mar; 61():44-9. PubMed ID: 22172600 [TBL] [Abstract][Full Text] [Related]
17. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone. O'Reilly RA Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398 [No Abstract] [Full Text] [Related]
19. Isolation and characterization of a new metabolite of phylloquinone in the rat. Matschiner JT; Bell RG; Amelotti JM; Knauer TE Biochim Biophys Acta; 1970 Feb; 201(2):309-15. PubMed ID: 5418726 [No Abstract] [Full Text] [Related]
20. [The identification of materials in toxocological analysis using Feldstein's extraction system, thin-layer chromatography and U.V. spectrophotometry. I. Basic materials]. Drost RH; Reith JF Pharm Weekbl; 1967 Dec; 102(51):1379-87. PubMed ID: 5594688 [No Abstract] [Full Text] [Related] [Next] [New Search]